DE EN

News

EU-LIFE Strategy Meeting 2019

EU-LIFE Strategy Meeting 2019
Thanks to the Babraham Institute for hosting the annual EU-LIFE Strategy Meeting, bringing together directors and main representatives from the 13 member institutes. CeMM is a proud member of EU-LIFE, profiting from the exchange of best practices and contributing to European research policy.  #EULIFEScience #researchexcellence #sciencepolicy
>7000 scientists and support personnel, >500 group leaders, >4000 publications, >100 running ERC Grants Partner Institutes: CRG Barcelona, VIB Flanders Institute for Biotechnology, Institute Curie Paris, MDC Berlin, Institute Gulbenkian Oeiras, European Institute of Oncology Milan, CEITEC Brno, NKI Amsterdam, FIMM Helsinki, BRIC Copenhagen, Babraham Institute Cambridge, FMI Basel, CeMM of the Austrian Academy of Sciences

Related Links

Share this article

News

at CeMM
Show all News
Organs age at different speeds: a blood test might soon tell which ones

Organs age at different speeds: a blood test might soon tell which ones

AI-based “tissue clocks” can estimate the biological age of human organs from histological images, researchers at the CeMM Research Center for…
A New Layer of Control for a Decades-Old Leukemia Drug

A New Layer of Control for a Decades-Old Leukemia Drug

How cells respond to the leukemia drug 6-thioguanine still holds surprises: A new study, led by researchers from CeMM and the University of Oxford…
Invisible threads: how our environment quietly shapes disease

Invisible threads: how our environment quietly shapes disease

From the air we breathe to the food we eat, we are constantly exposed to thousands of chemicals – yet how these exposures affect our health has…
Georg Winter elected as EMBO Member

Georg Winter elected as EMBO Member

CeMM warmly congratulates Georg Winter, AITHYRA Scientific Director and CeMM Adjunct Principal Investigator (both institutes of the Austrian Academy…
Mechanism of leukemia predisposition unraveled

Mechanism of leukemia predisposition unraveled

Spontaneous genetic mutations can disrupt normal blood development and drive pediatric leukemia. In addition to these acquired mutations, inherited…
Christoph Bock receives ERC Advanced Grant to engineer “living drugs” for cancer therapy

Christoph Bock receives ERC Advanced Grant to engineer “living drugs” for cancer therapy

Christoph Bock, Principal Investigator at CeMM and Professor of Medical Informatics at the Medical University of Vienna, has been awarded an ERC…
Christoph Bock contributes to Horizon Europe consortium investigating melanoma risk in young adults

Christoph Bock contributes to Horizon Europe consortium investigating melanoma risk in young adults

CeMM Principal Investigator and Medical University Professor Christoph Bock is part of the newly funded Horizon Europe Mission Cancer project…
Clarissa Campbell appointed Tenure-Track Professor at the University of Vienna

Clarissa Campbell appointed Tenure-Track Professor at the University of Vienna

CeMM congratulates Clarissa Campbell on her appointment as Tenure-Track Professor of Immunobiology at the University of Vienna. At CeMM, Clarissa…
Giulio Superti-Furga appointed Founding Director of Graz-based CORI Institute

Giulio Superti-Furga appointed Founding Director of Graz-based CORI Institute

CeMM warmly congratulates its founding director, Giulio Superti-Furga, on his appointment as the scientific founding director of the newly established…
19th Landsteiner Lecture with Jay Shendure

19th Landsteiner Lecture with Jay Shendure

Where do babies come from? Most adults should be able to answer that question, at least in broad terms. But on the cellular level, the story remains…
One Drug, Two Cleanup Crews: A built-in backup for targeted protein degradation

One Drug, Two Cleanup Crews: A built-in backup for targeted protein degradation

Targeted protein degradation has become one of the most promising strategies in modern drug discovery, enabling scientists to eliminate…
Maria Rescigno appointed to ERC Identification Committee

Maria Rescigno appointed to ERC Identification Committee

We congratulate our Scientific Director Maria Rescigno for beeing appointed by the European Commission to the high-level Identification Committee…
A SAGA of instability: Without scaffold, a key driver of childhood leukemia falls apart

A SAGA of instability: Without scaffold, a key driver of childhood leukemia falls apart

Researchers in the Seruggia group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and the CeMM Research Center for Molecular Medicine…
The tumor microbiota: A new frontier in cancer biology

The tumor microbiota: A new frontier in cancer biology

Recent research shows that tumors in different organs host microbial communities capable of influencing cancer biology, immune responses, and the…
Christoph Bock receives EP PerMed grant for personalized treatment in children

Christoph Bock receives EP PerMed grant for personalized treatment in children

CeMM PI Christoph Bock has been awarded funding through the European Partnership for Personalised Medicine (EP PerMed) under the 2025 Joint…
CeMM Research Report 2025: Front Row Science

CeMM Research Report 2025: Front Row Science

We are excited to present the CeMM Research Report 2025, Front Row Science! For this report, all CeMM members stepped out of their usual…
Cookie Extension Logo